• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDrugs

Drugs

Page 3 of 30
PoliticsTrump seeks to match US drug costs with cheaper ones abroad
By Derek Wallbank and BloombergMay 11, 2025
PoliticsTrump blasts Mexican President Claudia Sheinbaum because she won’t let him send U.S. troops into Mexico
By Aamer Madhani and The Associated PressMay 5, 2025
A man leans over and reaches for a bottle while standing in front of a shelf on medications.
EconomyTariffs threaten a pharmaceuticals shortage, as 95% of ibuprofen comes from China
By Sasha RogelbergApril 30, 2025
PoliticsTrump eyes new tariffs on semiconductors and pharmaceuticals as U.S. only makes 20% of world’s drugs and 0% of advanced logic chips
By Elaine Kurtenbach and The Associated PressApril 15, 2025
LArs Freurgaard Jorgensen and Ursula von der Leyen pictured among Danish business leaders in 2024.
HealthEurope’s pharma titans confront von der Leyen with threat to yank $113 billion from EU and relocate to U.S. as Trump plans ‘major’ tariffs
By Ryan HoggApril 9, 2025
RetailSiemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics
By AFPApril 3, 2025
A hand holding an Ivermectin tablet, with the bottle in the other hand
HealthIvermectin is being touted as a cure for COVID and cancer. Here’s what science says
By Beth GreenfieldApril 2, 2025
Photo of Mark Cuban
HealthMark Cuban warns Trump’s tariffs mean his Cost Plus Drugs ‘won’t have a choice’ but to raise prices for consumers
By Ani FreedmanApril 1, 2025
HealthMedication taken by 1 in 8 Americans linked to substantial increase in the risk of sudden cardiac death
By Ani FreedmanMarch 30, 2025
FinanceVietnam seizes 1.4 tons of ketamine as police bust country’s biggest synthetic drug factory
By AFPMarch 27, 2025
PoliticsChina says U.S. owes ‘big thank you’ on fentanyl, urges talks
By BloombergMarch 13, 2025
RetailRoche, Zealand Pharma in $5.3 billion pact for obesity drugs
By Paula Doenecke, Naomi Kresge and BloombergMarch 12, 2025
Interest in GLP-1 medications like Ozempic will continue to grow given the multiple health conditions they can improve.
CommentaryThe crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
By Wendy BarnesMarch 4, 2025
Ari Raptis, CEO of Talaria Transportation.
CommentaryI’m running a multimillion-dollar business—but it’s federally illegal
By Ari RaptisFebruary 25, 2025
Robert F. Kennedy Jr.
HealthWith RFK Jr. in charge, supplement makers see chance to cash in
By KFF Health News and Arthur AllenFebruary 25, 2025
1
  • 1
  • 2
  • 3
  • 4
  • 5
...30
Most Popular
Innovation
An MIT roboticist who cofounded bankrupt robot vacuum maker iRobot says Elon Musk’s vision of humanoid robot assistants is ‘pure fantasy thinking’An image of a popular article
By Marco Quiroz-GutierrezFebruary 25, 2026
Success
Jeff Bezos says being lazy, not working hard, is the root of anxiety: ‘The stress goes away the second I take that first step’An image of a popular article
By Sydney LakeFebruary 25, 2026
Economy
Trump claims America is ‘winning so much.’ The IMF agrees, adding that Trump’s trade policies are the only thing holding it back from even moreAn image of a popular article
By Tristan BoveFebruary 26, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.